CervoMed (CRVO) Shares Outstanding (Diluted) (2011 - 2026)
CervoMed (CRVO) reported Shares Outstanding (Diluted) of 8.7 million for Q2 2026, unchanged from 8.7 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Shares Outstanding (Diluted) (2011 - 2026) Analysis & Trends
Dating back to Q4 2011, CervoMed's Shares Outstanding (Diluted) record includes 59 quarters.
- Shares Outstanding (Diluted) has a five-year compound annual growth rate of 32.1% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 8.7 million in FY2024 (+131.0%), 3.77 million in FY2023 (+627.0%), 518,140 in FY2022 (-76.0%) and 2.16 million in FY2021 (unchanged).
- Year over year, Shares Outstanding (Diluted) gained in four of the last eight quarters, with growth averaging 65.5%.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q2 2024 (growth of 627.0%); the low point was Q3 2022 (a decline of 76.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 8.7 million (Q1 2026), 8.7 million (Q4 2025) and 8.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | CervoMed | 30.02 Mn | 30.02 Mn | - | 8.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 8.70 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | 3.77 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 3.77 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | 518,140.00 |
| Mar 31, 2023 | 518,140.00 |
| Dec 31, 2022 | 518,140.00 |
| Sep 30, 2022 | 518,140.00 |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 2.16 Mn |
API Access
CervoMed Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();